| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0008 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.005 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |